Global Clinical Trials Market Size & Outlook, 2026-2033
Global clinical trials market, 2021-2033 (US$M)
Related Markets
Global clinical trials market highlights
- The global clinical trials market generated a revenue of USD 88,972.1 million in 2025 and is expected to reach USD 158,412.1 million by 2033.
- The market is expected to grow at a CAGR (2026 - 2033) of 7.7% by 2033.
- In terms of segment, phase iii accounted for a revenue of USD 50,592.5 million in 2025.
- Phase I is the most lucrative phase segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2025.
- Country-wise, Australia is expected to register the highest CAGR from 2026 to 2033.
Global data book summary
| Market revenue in 2025 | USD 88,972.1 million |
| Market revenue in 2033 | USD 158,412.1 million |
| Growth rate | 7.7% (CAGR from 2026 to 2033) |
| Largest segment | Phase iii |
| Fastest growing segment | Phase I |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Phase II, Phase III, Phase IV, Phase I |
Other key industry trends
- In terms of revenue, the North America accounted for 50.7% of the global clinical trials market in 2025.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, Australia is the fastest growing regional market and is projected to reach USD 3,973.7 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clinical Trials Market Scope
Clinical Trials Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Caidya | View profile | 1001-5000 | Morrisville, North Carolina, United States, North America | https://www.caidya.com |
| Syneos Health | View profile | 1001-5000 | Morrisville, North Carolina, United States, North America | https://www.syneoshealth.com/ |
| PAREXEL | View profile | 10001+ | Waltham, Massachusetts, United States, North America | http://www.parexel.com |
| SGS AG | View profile | 103193 | 1 Place des Alpes, P.O. Box 2152, Geneva, Switzerland, CH-1211 | https://www.sgs.com |
| IQVIA Holdings Inc | View profile | 87000 | 2400 Ellis Road, Durham, NC, United States, 27703 | https://www.iqvia.com |
| Wuxi AppTec Co Ltd | View profile | 41116 | 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China, People's Republic of, 200131 | https://www.wuxiapptec.com |
| Icon PLC | View profile | 41150 | South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 | https://www.iconplc.com |
| Novo Nordisk A/S ADR | View profile | 66015 | Novo Alle 1, Bagsvaerd, Denmark, 2880 | https://www.novonordisk.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Labcorp Holdings Inc | View profile | 67000 | 358 South Main Street, Burlington, NC, United States, 27215 | https://www.labcorp.com |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
Global clinical trials market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trials market will help companies and investors design strategic landscapes.
Phase iii was the largest segment with a revenue share of 56.86% in 2025. Horizon Databook has segmented the Global clinical trials market based on phase ii, phase iii, phase iv, phase i covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Clinical Trials Phase Outlook (Revenue, USD Million, 2021-2033)
- Phase II
- Phase III
- Phase IV
- Phase I
- Global Clinical Trials Study Design Outlook (Revenue, USD Million, 2021-2033)
- Observational Trials
- Interventional Trials
- Expanded Access Trials
- Global Clinical Trials Indication Outlook (Revenue, USD Million, 2021-2033)
- Pain management
- Chronic Pain
- Acute Pain
- CNS conditions
- Epilepsy
- Parkinson's Disease (PD)
- Huntington's Disease
- Stroke
- Traumatic Brain Injury (TBI)
- Amyotrophic Lateral Sclerosis (ALS)
- Muscle Regeneration
- Others
- Diabetes
- Cardiovascular
- Obesity
- Others
- Autoimmune/Inflammation
- Multiple Sclerosis
- Osteoarthritis
- Others
- Rheumatoid Arthritis
- Irritable Bowel Syndrome (IBS)
- Oncology
- Solid Tumors
- Blood Cancer
- Others
- Pain management
- Global Clinical Trials Service Type Outlook (Revenue, USD Million, 2021-2033)
- Analytical Testing Services
- Clinical Trial Data Management Services
- Others
- Protocol Designing
- Patient Recruitment
- Laboratory Services
- Site Identification
- Global Clinical Trials Sponser Outlook (Revenue, USD Million, 2021-2033)
- Medical Device Companies
- Pharmaceutical & Biopharmaceutical Companies
- Others
Reasons to subscribe to Global clinical trials market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global clinical trials market databook
-
Our clientele includes a mix of clinical trials market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global clinical trials market , including forecasts for subscribers. This global databook contains high-level insights into Global clinical trials market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global clinical trials market size, by regions, 2021-2033 (US$M)
Top 10 countries: Clinical trials market size, 2025 (US$M)
Global clinical trials market share, by phase, 2025 & 2033 (%, US$M)
Clinical trials market: Opportunity assessment by country
Global clinical trials market, by region, 2025 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
